NASDAQ:LGND   Ligand Pharmaceuticals Incorporated
3
Notes on chart. No edge into earnings - even a straddle is risky as it may not make "the move" on it's report.

Disclaimer

The information and publications are not meant to be, and do not constitute, financial, investment, trading, or other types of advice or recommendations supplied or endorsed by TradingView. Read more in the Terms of Use.